Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

Clinical trial NCT06260033 · RECRUITING

Trial details

NCT number: NCT06260033
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Estrogen Receptor-Positive Breast Carcinoma Metastatic Breast Carcinoma

Start date: 2024-07-23
Primary completion: 2026-10-29
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.